Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...

Novo Nordisk A/S (NVO) has slashed prices for its blockbuster weight-loss drug Wegovy as competition in the obesity drug market heats up, with ...

The discounted price is aimed at uninsured patients and those whose insurance doesn't cover weight-loss medications like Wegovy. The move follows a similar price reduction by competitor Eli Lilly ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford the $1, ...

Eli Lilly began offering vials of the two lowest ... Danish drugmaker Novo Nordisk will also offer home delivery of Wegovy, which can cost patients more than $1,000 a month if they do not ...

Eli Lilly began offering vials of the two lowest ... Novo said its discounted Wegovy would be available in pens of all dosage strengths to uninsured patients or eligible patients with commercial ...

Strong demand for both Wegovy and Eli Lilly’s Zepbound led to shortages of those products. Compounding pharmacies pounced, taking market share with their custom-made, lower-cost versions of GLP ...

ELI LILLY CUTS PRICES FOR ZEPBOUND WEIGHT-LOSS DRUG AGAIN Those who are eligible can schedule shipments of their Wegovy prescriptions directly to their home through the pharmacy service.

Novo Nordisk A/S is following in rival Eli Lilly & Co.’s footsteps by selling its hit weight-loss drug Wegovy directly to US ...

Last week, Eli Lilly (LLY) said it would cut the monthly ... the drugs during the shortage will have to wind down production. Wegovy and Zepbound are part of a GLP-1 class of treatments that ...